DK1071955T4 - Forbedrede immundiagnostiske assays, som anvender reduktionsmidler - Google Patents

Forbedrede immundiagnostiske assays, som anvender reduktionsmidler

Info

Publication number
DK1071955T4
DK1071955T4 DK99920678T DK99920678T DK1071955T4 DK 1071955 T4 DK1071955 T4 DK 1071955T4 DK 99920678 T DK99920678 T DK 99920678T DK 99920678 T DK99920678 T DK 99920678T DK 1071955 T4 DK1071955 T4 DK 1071955T4
Authority
DK
Denmark
Prior art keywords
recombinant protein
purification
reducing agents
diagnostic assays
recombinant
Prior art date
Application number
DK99920678T
Other languages
Danish (da)
English (en)
Other versions
DK1071955T3 (da
Inventor
Geert Maertens
Joost Louwagie
Alfons Bosman
Erwin Sablon
Maan Zrein
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1071955(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of DK1071955T3 publication Critical patent/DK1071955T3/da
Application granted granted Critical
Publication of DK1071955T4 publication Critical patent/DK1071955T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
DK99920678T 1998-04-17 1999-04-15 Forbedrede immundiagnostiske assays, som anvender reduktionsmidler DK1071955T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98870087 1998-04-17
PCT/EP1999/002547 WO1999054735A1 (en) 1998-04-17 1999-04-15 Improved immunodiagnostic assays using reducing agents

Publications (2)

Publication Number Publication Date
DK1071955T3 DK1071955T3 (da) 2005-02-07
DK1071955T4 true DK1071955T4 (da) 2009-06-15

Family

ID=8237028

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99920678T DK1071955T4 (da) 1998-04-17 1999-04-15 Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
DK04103238T DK1471074T3 (da) 1998-04-17 1999-04-15 Fremgangsmåder til forbedring af konformationen af proteiner ved hjælp af reduktionsmidler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04103238T DK1471074T3 (da) 1998-04-17 1999-04-15 Fremgangsmåder til forbedring af konformationen af proteiner ved hjælp af reduktionsmidler

Country Status (22)

Country Link
US (1) US7935490B2 (pt)
EP (2) EP1471074B1 (pt)
JP (2) JP2002512370A (pt)
KR (1) KR20010042807A (pt)
CN (1) CN1305589A (pt)
AT (2) ATE401340T1 (pt)
AU (1) AU751362B2 (pt)
BR (1) BRPI9909678B8 (pt)
CA (2) CA2658218C (pt)
CY (1) CY1108424T1 (pt)
CZ (1) CZ298268B6 (pt)
DE (2) DE69939132D1 (pt)
DK (2) DK1071955T4 (pt)
ES (2) ES2230851T5 (pt)
HK (1) HK1036653A1 (pt)
HU (1) HUP0101719A3 (pt)
IL (1) IL138791A0 (pt)
PL (1) PL343469A1 (pt)
PT (2) PT1071955E (pt)
TR (4) TR200101648T2 (pt)
WO (1) WO1999054735A1 (pt)
ZA (1) ZA200005445B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140217A0 (en) * 1998-06-24 2002-02-10 Innogenetics Nv Particles of hcv envelope proteins: use for vaccination
AU9215101A (en) * 2000-08-17 2002-02-25 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
AU2002257392B2 (en) 2001-04-24 2007-05-10 Innogenetics N.V. Core-glycosylated hcv envelope proteins
JP2004108914A (ja) * 2002-09-18 2004-04-08 Kudo Norio コラーゲンの測定方法
CA2504711A1 (en) * 2002-11-08 2004-05-21 Innogenetics N.V. Hcv vaccine compositions comprising e1 and ns3 peptides
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
EP1691198B1 (en) * 2003-10-28 2010-10-20 Advanced Life Science Institute, Inc. Method of detecting hepatitis c virus
EP2041572A1 (en) * 2006-07-07 2009-04-01 Pall Corporation Use of denaturing agents during affinity capture
US20100304353A1 (en) * 2007-07-16 2010-12-02 Pfizer Inc Methods of improving a genomic marker index of dairy animals and products
AU2008300011A1 (en) * 2007-09-12 2009-03-19 Pfizer, Inc. Methods of using genetic markers and related epistatic interactions
JP2011501659A (ja) * 2007-10-03 2011-01-13 ファイザー・インク 有角および無角ウシの遺伝子マーカーおよび関連する方法
WO2009085689A2 (en) * 2007-12-17 2009-07-09 Pfizer Inc. Methods of improving genetic profiles of dairy animals and products
JP5476376B2 (ja) * 2008-07-16 2014-04-23 ラジオメーター・メディカル・アー・ペー・エス 高性能固相
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
US10088483B2 (en) 2014-10-29 2018-10-02 Abbott Laboratories Subject anti-HCV antibody detection assays employing NS3 capture peptides
CN109870581B (zh) * 2017-12-04 2021-05-04 厦门万泰凯瑞生物技术有限公司 一种定量检测HBsAg的试剂盒及方法
CN109678954B (zh) * 2018-12-29 2022-01-07 山东莱博生物科技有限公司 一对能够特异性识别hcv ns3蛋白的单克隆抗体及其应用
CN110988362B (zh) * 2019-12-20 2023-11-14 迈克生物股份有限公司 抗组蛋白抗体测定试剂、试剂盒及其使用方法
CN112225783B (zh) * 2020-09-16 2021-08-31 东莞市朋志生物科技有限公司 Hcv重组抗原及其突变体
CN112285361B (zh) * 2020-09-27 2023-12-05 中国人民解放军空军军医大学 排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
CN113219169B (zh) * 2021-05-22 2021-12-17 北京金诺百泰生物技术有限公司 生物检测用封闭剂及其制备方法、包被板及应用该包被板的试剂盒
CN115112897A (zh) * 2021-12-10 2022-09-27 中山大学附属第八医院（深圳福田） 一种用于鉴别抗体检测生物学假阳性的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139526A2 (en) * 1983-10-20 1985-05-02 Warner-Lambert Company An insolubilized stable specific binding protein
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
DE68907996T2 (de) 1988-05-11 1994-01-05 Abbott Lab Verfahren zur Erhöhung der Spezifizität in kompetitiven Immuntests.
US4923967A (en) * 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
ATE433460T1 (de) 1990-04-04 2009-06-15 Novartis Vaccines & Diagnostic Protease von hepatitis c virus
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
JP3225468B2 (ja) 1992-08-28 2001-11-05 ダイナボット株式会社 抗体測定用試薬
CA2139100C (en) 1993-04-27 2009-06-23 Geert Maertens New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
EP0992580B1 (en) 1993-11-04 2005-03-09 Innogenetics N.V. Immunodominant human T-cell epitopes of Hepatitis C virus
ES2167372T3 (es) 1994-06-23 2002-05-16 Energy Answers Corp Sistema para la obtencion de productos derivados de la ceniza y de energia a partir de residuos rechazados.
DE69526636D1 (de) * 1994-07-29 2002-06-13 Innogenetics Nv Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
EP1076092A3 (en) 1994-10-21 2001-03-28 Innogenetics N.V. Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
US5616460A (en) 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
ATE311463T1 (de) 1996-05-24 2005-12-15 Chiron Corp Fusionsprotein mit multiplen epitopen
WO1998030356A1 (en) * 1997-01-13 1998-07-16 Rodel, Inc. Polymeric polishing pad having photolithographically induced surface pattern(s) and methods relating thereto

Also Published As

Publication number Publication date
CY1108424T1 (el) 2014-04-09
DK1071955T3 (da) 2005-02-07
WO1999054735A1 (en) 1999-10-28
CA2658218C (en) 2014-10-28
ATE401340T1 (de) 2008-08-15
ES2230851T3 (es) 2005-05-01
DE69920895T3 (de) 2009-09-03
ES2310701T3 (es) 2009-01-16
DE69920895T2 (de) 2005-10-13
ZA200005445B (en) 2003-01-06
EP1471074A2 (en) 2004-10-27
CA2324970C (en) 2009-06-30
DE69939132D1 (de) 2008-08-28
CN1305589A (zh) 2001-07-25
PL343469A1 (en) 2001-08-13
CZ20003819A3 (cs) 2001-10-17
EP1071955B1 (en) 2004-10-06
EP1471074A3 (en) 2004-11-10
PT1071955E (pt) 2005-02-28
HK1036653A1 (en) 2002-01-11
ES2230851T5 (es) 2009-06-25
DK1471074T3 (da) 2008-11-17
JP2005185285A (ja) 2005-07-14
US20060263854A1 (en) 2006-11-23
EP1471074B1 (en) 2008-07-16
TR200003024T2 (tr) 2000-12-21
TR200101647T2 (tr) 2002-06-21
JP3974620B2 (ja) 2007-09-12
IL138791A0 (en) 2001-10-31
KR20010042807A (ko) 2001-05-25
HUP0101719A3 (en) 2006-05-29
CA2324970A1 (en) 1999-10-28
HUP0101719A2 (hu) 2001-09-28
EP1071955B2 (en) 2009-02-18
DE69920895D1 (de) 2004-11-11
TR200101648T2 (tr) 2002-06-21
BR9909678A (pt) 2000-12-19
JP2002512370A (ja) 2002-04-23
PT1471074E (pt) 2008-10-23
CA2658218A1 (en) 1999-10-28
ATE278960T1 (de) 2004-10-15
US7935490B2 (en) 2011-05-03
AU751362B2 (en) 2002-08-15
BR9909678B1 (pt) 2013-11-12
BRPI9909678B8 (pt) 2021-05-25
CZ298268B6 (cs) 2007-08-08
EP1071955A1 (en) 2001-01-31
TR200202213T2 (tr) 2002-11-21
AU3817199A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
DK1071955T3 (da) Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
DK1075488T3 (da) Proteinoprensning ved ionbytningskromatografi
WO2004024866A3 (en) Protein purification
ID23172A (id) Metode yang diperbaiki untuk pengolahan protein c teraktivasi
DE69409457D1 (de) Mittel zur Entfernung von Photoresist, das zur Verminderung von Metallkorrosion reduzierende Stoffe enthält
BR9714505A (pt) para o diabetes.
NO983603L (no) Substituerte sulfonsyre N-[(aminoiminometyl)-fenylalkyl]-azaheterocyklamid-forbindelser
BR0202431A (pt) Processo para a purificação de proteinas farmacologicamente ativas através de cromatografia por troca catiÈnica
ES2177213T3 (es) Botella cubierta por un manguito encogible.
NO992470L (no) 2-amidazolinyl-amino-indolforbindelser anvendelige som <alfa>-2-adreno-reseptoragonister
ES2136458T3 (es) Metodo para separar la metionina n-terminal.
DK255189A (da) Hydrogeler, som absorberer ultraviolet lys
DK1681299T3 (da) Fremgangsmåde til rensning af højt anioniske proteiner
BR9107052A (pt) Controle de processo aperfeiçoado para purificaçao de parafinas lineares.
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DK0848713T3 (da) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som antipsykotiske midler
ES2193349T3 (es) Metodo para la produccion de rdspa alfa1.
DK417886A (da) N-sulfenylerede benzensulfonsyreamider, fremgangsmaade til fremstilling heraf samt deres anvendelse som fungicider
DE50301658D1 (de) Positionsschalter
GT199800028A (es) Metodo de purificacion de 1, 3, 5-triisopropilbenceno.
DK0912498T3 (da) 4(4-oxocyclohexyl)-benzamider som mellemrpodukter til lægemidler
ITNA960015A0 (it) Biodepuratore biologico per imbarcazioni oscillante.
UA2876S (uk) Ковпачки (на пляшки)